VIA
PRAH

Vident Investment Advisory’s PRA Health Sciences, Inc. PRAH Stock Holding History

Vident Investment Advisory’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,241
Closed -$247K – 830
2017
Q3 		$247K Buy
+3,241
New +$245K 0.01% 680

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vident Investment Advisory's PRAH Position: Q4 2017 in Review

Vident Investment Advisory sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 3,241 shares — an estimated $247K sold.

Vident Investment Advisory first reported a position in PRAH in Q3 2017 and held it in 1 quarter. The position peaked at $247K in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Vident Investment Advisory reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Vident Investment Advisory sold 3,241 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $247K.
  • Vident Investment Advisory first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 1 quarter.
  • Vident Investment Advisory's PRA Health Sciences, Inc. position peaked at $247K in Q3 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.